BRIEF-Synergy pharmaceuticals says FDA set Jan 29, 2017 as PDUFA for constipation drug

* Synergy pharmaceuticals announces acceptance of new drug

application for plecanatide, a novel uroguanylin analog, in

chronic idiopathic constipation

Read more